Recall issued for two batches of GlaxoSmithKline UK’s Zovirax eye ointment after a pharmaceutical ingredient was found to contain metal particles outside the upper specification limit for particle size
A recall has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) for two batches of GlaxoSmithKline UK’s Zovirax eye ointment after a pharmaceutical ingredient was found to contain metal particles outside the upper specification limit for particle size.
The affected batches of the ointment, used to treat the herpes simplex virus, are 3L942 and 3M942 4.5g pack sizes which expire in October 2018 and January 2019. ‘Remaining stocks of the batches should be quarantined and returned to the original supplier for credit,’ said the MHRA.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here
